Literature DB >> 28912090

Immuno-oncology and Its Opportunities for Interventional Radiologists: Immune Checkpoint Inhibition and Potential Synergies with Interventional Oncology Procedures.

Ryan M Hickey1, Laura M Kulik2, Halla Nimeiri3, Aparna Kalyan3, Sheetal Kircher3, Kush Desai4, Ahsun Riaz4, Robert J Lewandowski4, Riad Salem5.   

Abstract

Immunotherapy, specifically the use of immune checkpoint inhibitors, offers a new approach to fighting cancer. Although the results of treatment with immune checkpoint inhibition alone have been remarkable for certain cancers, these results are not universal. Preclinical and early clinical studies indicate the potential for synergistic effects when immune checkpoint inhibition is combined with immunogenic local therapies such as ablation and embolization. This review offers an overview of immunology as it relates to immune checkpoint inhibition and the possibilities for synergy when combined with interventional radiology treatments.
Copyright © 2017 SIR. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2017        PMID: 28912090     DOI: 10.1016/j.jvir.2017.07.018

Source DB:  PubMed          Journal:  J Vasc Interv Radiol        ISSN: 1051-0443            Impact factor:   3.464


  8 in total

Review 1.  Developing a Roadmap for Interventional Oncology.

Authors:  Stefan O Schoenberg; Ulrike I Attenberger; Stephen B Solomon; Ralph Weissleder
Journal:  Oncologist       Date:  2018-06-29

Review 2.  The Evolving Landscape of Checkpoint Inhibitor Combination Therapy in the Treatment of Advanced Hepatocellular Carcinoma.

Authors:  Lin Liu; Shukui Qin; Yu Zhang
Journal:  Target Oncol       Date:  2021-02-02       Impact factor: 4.493

3.  Multifunctional Nanocarriers-Mediated Synergistic Combination of Immune Checkpoint Inhibitor Cancer Immunotherapy and Interventional Oncology Therapy.

Authors:  Bongseo Choi; Dong-Hyun Kim
Journal:  Adv Nanobiomed Res       Date:  2021-08-02

Review 4.  Combined with interventional therapy, immunotherapy can create a new outlook for tumor treatment.

Authors:  Tonglei Fang; Junyuan Xiao; Yiran Zhang; Haiyan Hu; Yueqi Zhu; Yingsheng Cheng
Journal:  Quant Imaging Med Surg       Date:  2021-06

Review 5.  Available ablation energies to treat cT1 renal cell cancer: emerging technologies.

Authors:  P J Zondervan; M Buijs; D M De Bruin; O M van Delden; K P Van Lienden
Journal:  World J Urol       Date:  2018-11-17       Impact factor: 4.226

Review 6.  Advances in study of the sequence of lung tumor biopsy and thermal ablation.

Authors:  Fanlei Kong; Chengen Wang; Yunfang Li; Xiaoguang Li
Journal:  Thorac Cancer       Date:  2020-12-28       Impact factor: 3.500

Review 7.  Cracking the Breast Cancer Glyco-Code through Glycan-Lectin Interactions: Targeting Immunosuppressive Macrophages.

Authors:  Nuno Lopes; Viviana G Correia; Angelina S Palma; Catarina Brito
Journal:  Int J Mol Sci       Date:  2021-02-17       Impact factor: 5.923

8.  Therapeutic strategies for gastroenteropancreatic neuroendocrine neoplasms: State-of-the-art and future perspectives.

Authors:  Elettra Merola; Andrea Michielan; Umberto Rozzanigo; Marco Erini; Sandro Sferrazza; Stefano Marcucci; Chiara Sartori; Chiara Trentin; Giovanni de Pretis; Franca Chierichetti
Journal:  World J Gastrointest Surg       Date:  2022-02-27
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.